{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:12:34Z","timestamp":1790197954503,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10495-025-02251-5","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:20:54Z","timestamp":1770668454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Removing therapy-induced senescent cancer cells targets and potentiates the response of pancreatic cancer cells toward PARP inhibitors as maintenance therapy"],"prefix":"10.1007","volume":"31","author":[{"given":"Yupeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue\u2019er","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingman","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoshi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1158\/0008-5472.CAN-24-0874","volume":"84","author":"P Storz","year":"2024","unstructured":"Storz P (2024) Earliest metabolic changes associated with the initiation of pancreatic cancer. Cancer Res 84:2225\u20132226","journal-title":"Cancer Res"},{"key":"2251_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5582\/bst.2024.01156","volume":"18","author":"H Momose","year":"2024","unstructured":"Momose H, Kudo S, Yoshida T, Hasui N, Matsuki R, Kogure M et al (2024) Trends in the treatment of advanced pancreatic cancer. Biosci Trends 18:224\u2013232","journal-title":"Biosci Trends"},{"key":"2251_CR3","doi-asserted-by":"crossref","unstructured":"Li X, Li C, Jin J, Wang J, Huang J, Ma Z et al (2018) High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects. EBioMedicine 38:47\u201356","DOI":"10.1016\/j.ebiom.2018.11.025"},{"key":"2251_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.gendis.2023.02.014","volume":"11","author":"X Fu","year":"2024","unstructured":"Fu X, Li P, Zhou Q, He R, Wang G, Zhu S et al (2024) Mechanism of PARP inhibitor resistance and potential overcoming strategies. Genes Dis 11:306\u2013320","journal-title":"Genes Dis"},{"key":"2251_CR5","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1158\/0008-5472.CAN-24-1404","volume":"85","author":"I Tabet","year":"2025","unstructured":"Tabet I, Orhan E, Candiello E, Fenou L, Velazquez C, Orsetti B et al (2025) Replication-Poison treatment in BRCA1-Deficient breast cancer causes MRE11 Over-Resection that induces Single-Stranded DNA accumulation and mitotic catastrophe. Cancer Res 85:1410\u20131423","journal-title":"Cancer Res"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1038\/onc.2017.40","volume":"36","author":"V Colicchia","year":"2017","unstructured":"Colicchia V, Petroni M, Guarguaglini G, Sardina F, Sahun-Roncero M, Carbonari M et al (2017) PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. Oncogene 36:4682\u20134691","journal-title":"Oncogene"},{"key":"2251_CR7","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1158\/0008-5472.CAN-25-0831","volume":"85","author":"Z Gohari","year":"2025","unstructured":"Gohari Z, Stojanovic L, Rassool FV (2025) Combining STING agonists with PARP inhibitors mounts an NK-Dependent defense against Therapy-Resistant breast cancer. Cancer Res 85:1747\u20131749","journal-title":"Cancer Res"},{"key":"2251_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1158\/1535-7163.MCT-24-0210","volume":"24","author":"VM Valvo","year":"2025","unstructured":"Valvo VM, Zhang Q, Jiang L, Holcomb EA, Pearson AN, Edmunds AG et al (2025) Olaparib and radiotherapy induce type I Interferon- and CD8\u2009+\u2009T Cell-Dependent sensitization to immunotherapy in pancreatic cancer. Mol Cancer Ther 24:843\u2013858","journal-title":"Mol Cancer Ther"},{"key":"2251_CR9","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1038\/s41467-024-46593-1","volume":"15","author":"W Fried","year":"2024","unstructured":"Fried W, Tyagi M, Minakhin L, Chandramouly G, Tredinnick T, Ramanjulu M et al (2024) Discovery of a small-molecule inhibitor that traps poltheta on DNA and synergizes with PARP inhibitors. Nat Commun 15:2862","journal-title":"Nat Commun"},{"key":"2251_CR10","doi-asserted-by":"crossref","unstructured":"Luo Y, Nie M, Chen Y, Huang X, Cui X, Lin W et al (2025) Clinical application of PARP1 inhibitors and challenges in cancer therapy. Curr Cancer Drug Targets","DOI":"10.2174\/0115680096327635241021115944"},{"key":"2251_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ et al (2019) Maintenance Olaparib for germline BRCA-Mutated metastatic pancreatic cancer. N Engl J Med 381:317\u2013327","journal-title":"N Engl J Med"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41416-020-01238-0","volume":"124","author":"G Pai Bellare","year":"2021","unstructured":"Pai Bellare G, Saha B, Patro BS (2021) Targeting autophagy reverses de Novo resistance in homologous recombination repair proficient breast cancers to PARP Inhibition. Br J Cancer 124:1260\u20131274","journal-title":"Br J Cancer"},{"key":"2251_CR13","doi-asserted-by":"publisher","first-page":"115024","DOI":"10.1016\/j.bcp.2022.115024","volume":"199","author":"G Pai Bellare","year":"2022","unstructured":"Pai Bellare G, Sankar Patro B (2022) Resveratrol sensitizes breast cancer to PARP inhibitor, Talazoparib through dual Inhibition of AKT and autophagy flux. Biochem Pharmacol 199:115024","journal-title":"Biochem Pharmacol"},{"key":"2251_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1631\/jzus.B2200178","volume":"24","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Li H, Guo Q, Hui H (2023) Multiple characteristic alterations and available therapeutic strategies of cellular senescence. J Zhejiang Univ Sci B 24:101\u2013114","journal-title":"J Zhejiang Univ Sci B"},{"key":"2251_CR15","doi-asserted-by":"publisher","first-page":"eadg7291","DOI":"10.1126\/scitranslmed.adg7291","volume":"15","author":"LI Prieto","year":"2023","unstructured":"Prieto LI, Sturmlechner I, Goronzy JJ, Baker DJ (2023) Senescent cells as thermostats of antitumor immunity. Sci Transl Med 15:eadg7291","journal-title":"Sci Transl Med"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"188994","DOI":"10.1016\/j.bbcan.2023.188994","volume":"1878","author":"T Saleh","year":"2023","unstructured":"Saleh T, Bloukh S, Hasan M, Shboul SA (2023) Therapy-induced senescence as a component of tumor biology: evidence from clinical cancer. Biochim Biophys Acta Rev Cancer 1878:188994","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2251_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41420-023-01454-6","volume":"9","author":"BT Graff","year":"2023","unstructured":"Graff BT, Palanivel C, Jenkins CB, Baranowska-Kortylewicz J, Yan Y (2023) Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms. Cell Death Discov 9:162","journal-title":"Cell Death Discov"},{"key":"2251_CR18","doi-asserted-by":"publisher","first-page":"722205","DOI":"10.3389\/fcell.2021.722205","volume":"9","author":"J Yang","year":"2021","unstructured":"Yang J, Liu M, Hong D, Zeng M, Zhang X (2021) The Paradoxical role of cellular senescence in cancer. Front Cell Dev Biol 9:722205","journal-title":"Front Cell Dev Biol"},{"key":"2251_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bcp.2018.12.013","volume":"162","author":"T Saleh","year":"2019","unstructured":"Saleh T, Tyutyunyk-Massey L, Murray GF, Alotaibi MR, Kawale AS, Elsayed Z et al (2019) Tumor cell escape from therapy-induced senescence. Biochem Pharmacol 162:202\u2013212","journal-title":"Biochem Pharmacol"},{"key":"2251_CR20","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1038\/s41467-019-10460-1","volume":"10","author":"H Fleury","year":"2019","unstructured":"Fleury H, Malaquin N, Tu V, Gilbert S, Martinez A, Olivier MA et al (2019) Exploiting interconnected synthetic lethal interactions between PARP Inhibition and cancer cell reversible senescence. Nat Commun 10:2556","journal-title":"Nat Commun"},{"key":"2251_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41419-019-1447-y","volume":"10","author":"Q Yu","year":"2019","unstructured":"Yu Q, Zhang M, Ying Q, Xie X, Yue S, Tong B et al (2019) Decrease of AIM2 mediated by Luteolin contributes to non-small cell lung cancer treatment. Cell Death Dis 10:218","journal-title":"Cell Death Dis"},{"key":"2251_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2017.05.016","volume":"402","author":"Z Bai","year":"2017","unstructured":"Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y et al (2017) BZML, a novel Colchicine binding site inhibitor, overcomes multidrug resistance in A549\/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe. Cancer Lett 402:81\u201392","journal-title":"Cancer Lett"},{"key":"2251_CR23","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/1751-7915.14297","volume":"16","author":"X Ye","year":"2023","unstructured":"Ye X, Wang J, Xu P, Yang X, Shi Q, Liu G et al (2023) Peptide MSI-1 inhibited MCR-1 and regulated outer membrane vesicles to combat immune evasion of Escherichia coli. Microb Biotechnol 16:1755\u20131773","journal-title":"Microb Biotechnol"},{"key":"2251_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M (2018) Hallmarks of cellular senescence. Trends Cell Biol 28:436\u2013453","journal-title":"Trends Cell Biol"},{"key":"2251_CR25","doi-asserted-by":"publisher","first-page":"eabo0322","DOI":"10.1126\/sciadv.abo0322","volume":"8","author":"B Jiang","year":"2022","unstructured":"Jiang B, Wu X, Meng F, Si L, Cao S, Dong Y et al (2022) Progerin modulates the IGF-1R\/Akt signaling involved in aging. Sci Adv 8:eabo0322","journal-title":"Sci Adv"},{"key":"2251_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mad.2008.04.011","volume":"130","author":"MA Sliwinska","year":"2009","unstructured":"Sliwinska MA, Mosieniak G, Wolanin K, Babik A, Piwocka K, Magalska A et al (2009) Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech Ageing Dev 130:24\u201332","journal-title":"Mech Ageing Dev"},{"issue":"Pt 20","key":"2251_CR27","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1242\/jcs.113.20.3613","volume":"113","author":"DJ Kurz","year":"2000","unstructured":"Kurz DJ, Decary S, Hong Y, Erusalimsky JD (2000) Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113(Pt 20):3613\u20133622","journal-title":"J Cell Sci"},{"key":"2251_CR28","doi-asserted-by":"publisher","first-page":"119174","DOI":"10.1016\/j.bbamcr.2021.119174","volume":"1869","author":"Z Bai","year":"2022","unstructured":"Bai Z, Zhou Y, Ye X, Li Y, Peng Y, Guan Q et al (2022) Survivin suppression heightens BZML-induced mitotic catastrophe to overcome multidrug resistance by removing therapy-induced senescent A549\/Taxol cells. Biochim Biophys Acta Mol Cell Res 1869:119174","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2251_CR29","doi-asserted-by":"publisher","first-page":"118712","DOI":"10.1016\/j.bbamcr.2020.118712","volume":"1867","author":"W Gou","year":"2020","unstructured":"Gou W, Li Z, Xu X, Shen J, Guo M, Zhou X et al (2020) ZX-29, a novel ALK inhibitor, induces apoptosis via ER stress in ALK rearrangement NSCLC cells and overcomes cell resistance caused by an ALK mutation. Biochim Biophys Acta Mol Cell Res 1867:118712","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2251_CR30","doi-asserted-by":"publisher","first-page":"e12450","DOI":"10.1111\/cpr.12450","volume":"51","author":"Z Bai","year":"2018","unstructured":"Bai Z, Gao M, Xu X, Zhang H, Xu J, Guan Q et al (2018) Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by Inhibition of autophagy in A549\/Taxol cells. Cell Prolif 51:e12450","journal-title":"Cell Prolif"},{"key":"2251_CR31","doi-asserted-by":"publisher","first-page":"33323","DOI":"10.1038\/srep33323","volume":"6","author":"S Lal","year":"2016","unstructured":"Lal S, Zarei M, Chand SN, Dylgjeri E, Mambelli-Lisboa NC, Pishvaian MJ et al (2016) WEE1 Inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner. Sci Rep 6:33323","journal-title":"Sci Rep"},{"key":"2251_CR32","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.21873\/anticanres.16754","volume":"43","author":"C Kim","year":"2023","unstructured":"Kim C, Kim D, Lee DS, Lee S, Yoo C, Kim KP (2023) PARP inhibitor sensitizes BRCA-mutant pancreatic cancer to oxaliplatin by suppressing the CDK1\/BRCA1 axis. Anticancer Res 43:5523\u20135534","journal-title":"Anticancer Res"},{"key":"2251_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00006676-200410000-00004","volume":"29","author":"P Loukopoulos","year":"2004","unstructured":"Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, Hirohashi S (2004) Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. Pancreas 29:193\u2013203","journal-title":"Pancreas"},{"key":"2251_CR34","doi-asserted-by":"publisher","first-page":"188914","DOI":"10.1016\/j.bbcan.2023.188914","volume":"1878","author":"J Calheiros","year":"2023","unstructured":"Calheiros J, Corbo V, Saraiva L (2023) Overcoming therapeutic resistance in pancreatic cancer: emerging opportunities by targeting BRCAs and p53. Biochim Biophys Acta Rev Cancer 1878:188914","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2251_CR35","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1091\/mbc.e11-10-0884","volume":"23","author":"A Freund","year":"2012","unstructured":"Freund A, Laberge RM, Demaria M, Campisi J (2012) Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell 23:2066\u20132075","journal-title":"Mol Biol Cell"},{"key":"2251_CR36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1158\/1541-7786.MCR-05-0121","volume":"3","author":"CM Aliouat-Denis","year":"2005","unstructured":"Aliouat-Denis CM, Dendouga N, Van den Wyngaert I, Goehlmann H, Steller U, van de Weyer I et al (2005) p53-independent regulation of p21Waf1\/Cip1 expression and senescence by Chk2. Mol Cancer Res 3:627\u2013634","journal-title":"Mol Cancer Res"},{"key":"2251_CR37","doi-asserted-by":"publisher","first-page":"188910","DOI":"10.1016\/j.bbcan.2023.188910","volume":"1878","author":"X Yu","year":"2023","unstructured":"Yu X, Zhu L, Wang T, Li L, Liu J, Che G et al (2023) Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors. Biochim Biophys Acta Rev Cancer 1878:188910","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2251_CR38","doi-asserted-by":"crossref","unstructured":"Ye M, Li H, Luo H, Zhou Y, Luo W, Lin Z (2023) Potential antioxidative activity of homocysteine in erythrocytes under oxidative stress. Antioxid (Basel) 12","DOI":"10.3390\/antiox12010202"},{"key":"2251_CR39","doi-asserted-by":"publisher","first-page":"107943","DOI":"10.1016\/j.pharmthera.2021.107943","volume":"230","author":"A Basu","year":"2022","unstructured":"Basu A (2022) The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy. Pharmacol Ther 230:107943","journal-title":"Pharmacol Ther"},{"key":"2251_CR40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/1535-7163.MCT-23-0863","volume":"24","author":"HA Kenny","year":"2025","unstructured":"Kenny HA, Ip CKM, Kelliher L, Samantaray T, Kordylewicz K, Hoffmann R et al (2025) Navitoclax, a Bcl-2\/xL inhibitor, and YM155, a survivin inhibitor, in combination with Carboplatin, effectively inhibit ovarian cancer tumor growth. Mol Cancer Ther 24:1252\u20131264","journal-title":"Mol Cancer Ther"},{"key":"2251_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13046-021-02124-0","volume":"40","author":"C Coulson-Gilmer","year":"2021","unstructured":"Coulson-Gilmer C, Morgan RD, Nelson L, Barnes BM, Tighe A, Wardenaar R et al (2021) Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models. J Exp Clin Cancer Res 40:323","journal-title":"J Exp Clin Cancer Res"},{"key":"2251_CR42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1101\/gad.334516.119","volume":"34","author":"D Slade","year":"2020","unstructured":"Slade D (2020) PARP and PARG inhibitors in cancer treatment. Genes Dev 34:360\u2013394","journal-title":"Genes Dev"},{"key":"2251_CR43","doi-asserted-by":"publisher","first-page":"188965","DOI":"10.1016\/j.bbcan.2023.188965","volume":"1878","author":"Z Bai","year":"2023","unstructured":"Bai Z, Zhou Y, Peng Y, Ye X, Ma L (2023) Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment. Biochim Biophys Acta Rev Cancer 1878:188965","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2251_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41580-024-00738-8","volume":"25","author":"V Suryadevara","year":"2024","unstructured":"Suryadevara V, Hudgins AD, Rajesh A, Pappalardo A, Karpova A, Dey AK et al (2024) SenNet recommendations for detecting senescent cells in different tissues. Nat Rev Mol Cell Biol 25:1001\u20131023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2251_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-022-01360-x","volume":"15","author":"S Li","year":"2022","unstructured":"Li S, Wang L, Wang Y, Zhang C, Hong Z, Han Z (2022) The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. J Hematol Oncol 15:147","journal-title":"J Hematol Oncol"},{"key":"2251_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.redox.2015.04.009","volume":"5","author":"K Banerjee","year":"2015","unstructured":"Banerjee K, Mandal M (2015) Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells. Redox Biol 5:153\u2013162","journal-title":"Redox Biol"},{"key":"2251_CR47","doi-asserted-by":"crossref","unstructured":"Cayo A, Venturini W, Rebolledo-Mira D, Moore-Carrasco R, Herrada AA, Nova-Lamperti E et al (2023) Palbociclib-Induced cellular senescence is modulated by the mTOR complex 1 and autophagy. Int J Mol Sci 24","DOI":"10.3390\/ijms24119284"},{"key":"2251_CR48","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1038\/s41467-022-34890-6","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Azizian NG, Sullivan DK, Li Y (2022) mTOR Inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters. Nat Commun 13:7047","journal-title":"Nat Commun"},{"key":"2251_CR49","doi-asserted-by":"crossref","unstructured":"Huna A, Massemin A, Makulyte G, Flaman JM, Martin N, Bernard D (2024) Regulation of cell function and identity by cellular senescence. J Cell Biol 223","DOI":"10.1083\/jcb.202401112"},{"key":"2251_CR50","doi-asserted-by":"publisher","first-page":"1292053","DOI":"10.3389\/fragi.2023.1292053","volume":"4","author":"T Shreeya","year":"2023","unstructured":"Shreeya T, Ansari MS, Kumar P, Saifi M, Shati AA, Alfaifi MY et al (2023) Senescence: A DNA damage response and its role in aging and neurodegenerative diseases. Front Aging 4:1292053","journal-title":"Front Aging"},{"key":"2251_CR51","doi-asserted-by":"publisher","first-page":"e31187","DOI":"10.1002\/jcp.31187","volume":"239","author":"Y Zhong","year":"2024","unstructured":"Zhong Y, Wang G, Yang S, Zhang Y, Wang X (2024) The role of DNA damage in neural stem cells ageing. J Cell Physiol 239:e31187","journal-title":"J Cell Physiol"},{"key":"2251_CR52","doi-asserted-by":"publisher","first-page":"103048","DOI":"10.1016\/j.redox.2024.103048","volume":"70","author":"N Yu","year":"2024","unstructured":"Yu N, Pasha M, Chua JJE (2024) Redox changes and cellular senescence in alzheimer\u2019s disease. Redox Biol 70:103048","journal-title":"Redox Biol"},{"key":"2251_CR53","doi-asserted-by":"publisher","first-page":"e13948","DOI":"10.1111\/acel.13948","volume":"22","author":"H Power","year":"2023","unstructured":"Power H, Valtchev P, Dehghani F, Schindeler A (2023) Strategies for senolytic drug discovery. Aging Cell 22:e13948","journal-title":"Aging Cell"},{"key":"2251_CR54","doi-asserted-by":"crossref","unstructured":"Seiboldt T, Zeiser C, Nguyen D, Celikyurekli S, Herter S, Najafi S et al (2024) Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours. Br J Cancer","DOI":"10.1038\/s41416-024-02740-5"},{"key":"2251_CR55","doi-asserted-by":"publisher","first-page":"216965","DOI":"10.1016\/j.canlet.2024.216965","volume":"594","author":"C Palominos","year":"2024","unstructured":"Palominos C, Fuentes-Retamal S, Salazar JP, Guzman-Rivera D, Correa P, Mellado M et al (2024) Mitochondrial bioenergetics as a cell fate rheostat for responsive to Bcl-2 drugs: new cues for cancer chemotherapy. Cancer Lett 594:216965","journal-title":"Cancer Lett"},{"key":"2251_CR56","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s12094-022-03070-9","volume":"25","author":"I Ploumaki","year":"2023","unstructured":"Ploumaki I, Triantafyllou E, Koumprentziotis IA, Karampinos K, Drougkas K, Karavolias I et al (2023) Bcl-2 pathway Inhibition in solid tumors: a review of clinical trials. Clin Transl Oncol 25:1554\u20131578","journal-title":"Clin Transl Oncol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02251-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:01:51Z","timestamp":1774080111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02251-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02251-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial or personal relationships that may be perceived as influencing their work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"71"}}